Sardano Joseph C's Form 4/A amendment
AmendedSensus Healthcare, Inc.SRTS · filed Dec 16, 2021
- Accession no.
- 0001415889-21-006035
- Filed
- Dec 16, 2021
- Trade date
- Dec 13-14, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 15, 2021
This filing lists 2 non-derivative transactions. Open-market sales total $133.0K. It was filed 3 days after the trade.
This amendment replaces 0001415889-21-005956 (filed Dec 15, 2021).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sardano Joseph CCIK 0001300111 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These transactions were effected under a plan entered into pursuant to Rule 10b5-1 under Securities Exchange Act of 1934.
- F2
The sale prices range from $6.78 through $7.40.
Referenced by the price of 1 transaction in Table I.
- F3
The sale prices range from $6.86 through $7.46.
Referenced by the price of 1 transaction in Table I.